Annals of Tropical Medicine and Public Health
Home About us Ahead Of Print Instructions Submission Subscribe Advertise Contact e-Alerts Editorial Board Login 
Users Online:858
  Print this page  Email this page Small font sizeDefault font sizeIncrease font size
 


 
Table of Contents   
CASE REPORT  
Year : 2016  |  Volume : 9  |  Issue : 4  |  Page : 279-282
An uncommon presentation of progressive disseminated histoplasmosis


Departments of General Medicine, FCCM (NIMS), Consultant Intensivisit, Coordinator Medical Publications, Yashoda Hospital, Hyderabad, Telangana, India

Click here for correspondence address and email

Date of Web Publication28-Jun-2016
 

   Abstract 

Progressive disseminated histoplasmosis (PDH) caused by Histoplasma capsulatum generally develops in immunocompromised patients or those on long-term systemic corticosteroid therapy. Here, we report a case of PDH in an immunocompetent patient, which is a rare occurrence. A 56- year-old male patient, whose work often led him to caves, now reported with a low-grade fever and altered sensorium. Investigations revealed hyponatremia, bilateral adrenal enlargement, and mediastinal lymphadenopathy. A rare complication of the manifestations of histoplasmosis in an immunocompetent patient, in the form of ring lesions in the brain, came to light during the clinical investigations. The patient developed generalized tonic–clonic convulsions and needed care for the critical condition 2 weeks into treatment. This case report traces the clinical course, histological and serological findings, and response to amphotericin B therapy in the patient.

Keywords: Immunocompetent patient, progressive disseminated histoplasmosis (PDH), ring brain lesions

How to cite this article:
Agarwal VK, Prusty B S, Pereira KR. An uncommon presentation of progressive disseminated histoplasmosis. Ann Trop Med Public Health 2016;9:279-82

How to cite this URL:
Agarwal VK, Prusty B S, Pereira KR. An uncommon presentation of progressive disseminated histoplasmosis. Ann Trop Med Public Health [serial online] 2016 [cited 2019 Aug 23];9:279-82. Available from: http://www.atmph.org/text.asp?2016/9/4/279/184798

   Introduction Top


The first description of histoplasmosis was by an American physician named Samuel Taylor Darling in Panama, who described the disseminated form of the disease in a case from Martinique, France. Initially, the disease was attributed to miliary tuberculosis.[1] Progressive disseminated histoplasmosis (PDH) infection is caused by Histoplasma capsulatum, a dimorphic saprophytic fungus, residing in the soil, and found abundantly in caves. Infection to humans is mainly caused by inhalation of mycelial fragments and conidia.[2],[3] In India, a few cases have been reported most commonly from the eastern regions and in the soil of the Gangetic plains.[4],[5] There exists a spectrum of signs and symptoms of histoplasmosis that are dependent on the immune status of the patient and the intensity of exposure. Therefore, the patient may have an asymptomatic presentation or could present with PDH. Patients, when brought to hospitals could have respiratory failure, shock state, multiorgan dysfunction, and effects on liver, spleen, adrenals, mucocutaneous regions, and bone marrow.[6] Statistics reveal that 30-50% of the patients with PDH present with asymptomatic adrenal gland involvement, out of which few patients present with adrenal insufficiency.[7] We report a case of PDH in an immunocompetent patient presenting with bilateral adrenal mass associated with hypoadrenalism and coincident with cerebral ring enhancing lesion, which is seldom associated with histoplasmosis.[8]


   Case Report Top


A 56-year-old male patient, geologist by profession, was admitted to the hospital with altered sensorium. The patient was presently working in Hyderabad, Telangana, India and had a history of frequent work visits to caves in Visakhapatnam, Andhra Pradesh over the past 3 years. The patient presented with low-grade fever, accompanied by chills, and complained of anorexia and weight loss since 6 months. There was a spurt of hiccups since the past 2 days prior to admission. The patient was a habitual smoker, and smoked one packet of cigarettes every day since the last 30 years.

On examination, the patient appeared to be incoherent, slipping in and out of consciousness and had a thinly-built body (body mass index of 18.0). The patient's spleen was enlarged. On laboratory evaluation, the patient was found to have hyponatremia, with serum sodium level of 109 mEq/L. There was clubbing of fingers but without lymphadenopathy, anemia, or jaundice. The patient's pulse rate was recorded as 76 beats/min, blood pressure as 110/70 mm of Hg, respiratory rate as 23 breaths/min, and an oxygen saturation (Spo2) of 93% on room air. The other electrolyte levels were found normal. Further tests revealed leukopenic total leukocyte count (TLC) 3,300/min with adequate platelets and hemoglobin and hypothyroidism with thyroid stimulating hormone (TSH) 13.98 units. The patient's chest X-ray imaging was within normal limits. Ultrasound of the abdomen revealed splenomegaly, bilateral suprarenal space-occupying lesions suggestive of bilateral adrenal masses. Right 6.2 cm × 4.7 cm, left 7.5 cm × 4.3 cm with few central cystic lesions [Figure 1].
Figure 1: Ultrasound of the abdomen: An abdominal ultrasound was conducted and splenomegaly was observed. Seen in the image are bilateral suprarenal space occupying lesions suggestive of bilateral adrenal masses. Right 6.2 cm × 4.7 cm, left 7.5 cm × 4.3 cm with few central cystic lesions

Click here to view


An 18 fluorodeoxyglucose positron emission tomogram (18 FDG-PET) scan showed increased uptake in mediastinal lymph nodes, bilateral adrenal mass lesions [Figure 2], and non-FDG ring-enhancing lesion in the brain [Figure 3].
Figure 2: Bilateral adrenal mass lesions: An 18 flurodeoxyglucose positron emission tomography scan showed bilateral adrenal mass lesions

Click here to view
Figure 3: Non FDG ring enhancing lesion in the brain: The 18 fluorodeoxyglucose positron emission tomogram revealed non-FDG ring enhancing brain lesion

Click here to view


Computed tomography (CT)-guided adrenal biopsy showed well-formed granulomatous tissue with multinucleated giant cells, epithelial histiocytes, and lymphocytic mononuclear inflammatory infiltrate. Many round-to-oval periodic acid-Schiff (PAS) positive fungal organisms were observed, which was suggestive of histoplasmosis [Figure 4] and [Figure 5].
Figure 4: CT-guided adrenal biopsy: CT-guided adrenal biopsy showed many round to oval PAS positive fungal organisms, which was suggestive of histoplasmosis

Click here to view
Figure 5: Histology of CT-guided adrenal biopsy: Well-formed granulomatous tissue with multinucleate giant cells, epithelial histiocytes, and lymphocytic mononuclear inflammatory infiltrate were observed

Click here to view


The diagnosis of PDH, involving the brain, mediastinal lymph nodes, and bilateral adrenal glands, was made.

The hyponatremia was corrected with intravenous (IV) fluids and salts and for PDH, IV liposomal amphotericin B 3 mg/kg body weight was administered. The patient was human immune deficiency virus (HIV) negative and the cluster of differentiation (CD4) counts were within normal limits.

After 2 weeks of amphotericin B treatment, despite maintaining normal electrolytes, the patient developed an episode of generalized tonic–clonic seizures (GTCS) and was treated with lorazepam, followed by fosphenytoin. A magnetic resonance imaging (MRI) of the brain was done that showed the same findings as the PET scan [Figure 6].
Figure 6: MRI of the brain: An MRI of the brain was conducted when the patient developed an episode of generalized tonic–clonic seizures after 2 weeks of amphotericin B treatment. The findings of the MRI were similar to those observed in the PET scan

Click here to view


After 3 weeks of treatment with liposomal amphotericin B, the patient developed hypotension. The serum sodium level was recorded to be 119 meq/L, and potassium level was recorded to be 6.1 meq/L. The patient was managed with IV fluids. The patient's serum cortisol at 8 am was 3.64 µcg/dL (normal 4.3-22.4) and an initial hydrocortisone therapy was started and then changed to oral prednisolone 7.5 mg/day. The patient's plasma renin level was 3.22 ng/dL, which is the upper limit of the normal range.

After 4 weeks of liposomal amphotericin B treatment, oral itraconazole 200 mg twice daily was started and amphotericin B was stopped.


   Discussion Top


In the present case, the patient hails from Kolkata (Gangetic delta of East India), West Bengal, India from where most of the cases of PDH, have been reported in India.[4],[9],[10]

Our patient presented with low-grade fever, weight loss, generalized weakness anorexia, and bilateral adrenal enlargement. In addition, the patient had adrenal insufficiency, as diagnosed by low serum cortisol, hyponatremia (119 meq/L), hyperkalemia (6.1 meq/L) that continued, despite 3 weeks of treatment with liposomal amphotericin B.

18 FDG-PET scan revealed intensely increased uptake in both the adrenals, mediastinal lymph nodes, and non-FDG enhancing ring lesions in the brain. After 2 weeks of treatment, the patient developed GTCS, which was due to existing non-FDG enhancing ring lesion in the brain. A ring enhancing lesion in the brain in a PDH patient is uncommon when the patient is an immunocompetent adult.[9]

The patient was treated with liposomal amphotericin B for 4 weeks with a dose of 3 mg/kg body weight and followed by oral itraconazole twice daily that was advised for 1 year. The patient showed dramatic clinical response to treatment.


   Conclusion Top


This case report will significantly help the medical fraternity by bringing to light the possibility of brain lesions associated with histoplasmosis. Further, clinicians can be alerted to the possibility of finding the signs and symptoms of histoplasmosis in immunocompetent patients, contrary to the longstanding view of its predominant association with immunocompromised patients.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Darling ST. A protozoan general infection producing psuedotuberculosis in the lungs and focal necrosis in the liver, spleen, and lymph nodes. JAMA 1906;46:1283-5.  Back to cited text no. 1
    
2.
Lottenberg R, Waldman RH, Ajello L, Hoff GL, Bigler W, Zellner SR. Pulmonary histoplasmosis associated with exploration of a bat cave. Am J Epidemiol 1979;110:156-61.  Back to cited text no. 2
    
3.
Emmons CW. Isolation of histoplasma capsulatum from soil. Public Health Rep 1949;64:892-6.  Back to cited text no. 3
    
4.
Sanyal M, Thammayya A. Histoplasma capsulatum in the soil of Gangetic plain in India. Indian J Med Res 1975;63:1020-8.  Back to cited text no. 4
    
5.
Goswami RP, Pramanik N, Banerjee D, Raza MM, Guha SK, Maiti PK. Histoplasmosis in eastern India: The tip of the iceberg? Trans R Soc Trop Med Hyg 1999;93:540-2.  Back to cited text no. 5
    
6.
Gopalakrishnan R, Nambi PS, Ramasubramanian V, Abdul Ghafur K, Parameswaran A. Histoplasmosis in India: Truly uncommon or uncommonly recognised? J Assoc Physicians India 2012;60:25-8.  Back to cited text no. 6
    
7.
Kumar N, Singh S, Govil S. Adrenal histoplasmosis: Clinical presentation and imaging features in nine cases. Abdom Imaging 2003;28:703-8.   Back to cited text no. 7
    
8.
Wheat LJ, Batteiger BE, Sathapatayavongs B. Histoplasma capsulatum infections of the Central nervous system: A clinical review. Medicine (Baltimore) 1990;69:244-60.  Back to cited text no. 8
    
9.
Subramanian S, Abraham OC, Rupali P, Zachariah A, Mathews MS, Mathai D. Disseminated histoplasmosis. J Assoc Physicians India 2005;53:185-9.  Back to cited text no. 9
    
10.
Randhawa HS, Khan ZU. Histoplasmosis in India: Current status. Indian J Chest Dis Allied Sci 1994;36:193-213.  Back to cited text no. 10
    

Top
Correspondence Address:
Karishma Rosann Pereira
Yashoda Hospital, Malakpet, Hyderabad, Telangana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1755-6783.184798

Rights and Permissions


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *


    Abstract
   Introduction
   Case Report
   Discussion
   Conclusion
    References
    Article Figures

 Article Access Statistics
    Viewed1488    
    Printed35    
    Emailed1    
    PDF Downloaded24    
    Comments [Add]    

Recommend this journal